Cell isolation/separation market to be worth $5.1 b by 2019.
NEW YORK, N.Y., October 6, 2014 -- The global cell isolation market is expected to reach $5.1 billion by 2019, up from $2.5 billion in 2014, growing at a CAGR of 15.8 percent between 2014 to 2019, according to a new report.
The global cell isolation market is categorized by product, cell type, technique, application, end user, and geography.
The human cell isolation segment is expected to register the highest growth rate in the cell isolation market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human stem cell research and the increasing usage of stem cell for treating various disorders.
Furthermore, differentiated human cells are widely used by biotechnology and biopharmaceutical industries for obtaining various biotechnology products and biopharmaceuticals. This is another major reason for the growth of this market.
Major factors contributing to growth of the cell isolation market include the increasing usage of cell isolation in cancer research, expanding biotechnology and biopharmaceutical industries, technological advancements, high prevalence of infectious diseases, and rising aging population are likely to propel the growth of this market.
Government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2013, National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) provided up to $1.5 million funds to Stemcell Technologies (Canada) for the development of cell isolation technology, to augment the research of Human Immunodeficiency Virus (HIV) and other infectious diseases.
The relatively untapped markets of the Asian region and advent of microfluidics in cell isolation have opened an array of opportunities for the cell isolation market.
However, reluctance among researchers to use advanced cell isolation techniques and high cost of instruments are expected to restrain the growth of this market.
Moreover, there are various ethical issues related to embryonic stem cell research, which is expected to hinder the growth of this market to some extent.
The Asian region, stem cell isolation, and magnetic activated cell separators are expected to serve as new revenue pockets for the cell isolation market in the coming five years.
For more information, or to buy the report (MarketsandMarkets, 215 pages, $4,650), visit the following link.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Industry & Market Research|
|Publication:||Stem Cell Business News|
|Date:||Oct 6, 2014|
|Previous Article:||Stemedica: patent for use of multiple stem cell lines to treat ischemic stroke.|
|Next Article:||Graft-versus-host disease market to reach $409 m in four years.|